Shimazawa M - Search Results

1

Prevention of in vitro and in vivo acute ischemic neuronal damage by (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl) phenyl]-1-piperazinyl}-2-propanol dimethanesulfonate (SUN N8075), a novel neuroprotective agent with antioxidant properties.

Kotani Y, Morimoto N, Oida Y, Tamura Y, Tamura S, Inoue T, Shimazawa M, Yoshimura S, Iwama T, Hara H. Kotani Y, et al. Among authors: shimazawa m. Neuroscience. 2007 Nov 23;149(4):779-88. doi: 10.1016/j.neuroscience.2007.08.029. Epub 2007 Sep 12. Neuroscience. 2007. PMID: 17945433

2

[The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].

Fujishima Y, Hara H, Shimazawa M, Yokota K, Sukamoto T. Fujishima Y, et al. Among authors: shimazawa m. Nihon Yakurigaku Zasshi. 1994 Jul;104(1):19-29. doi: 10.1254/fpj.104.19. Nihon Yakurigaku Zasshi. 1994. PMID: 8076888 Japanese.

3

Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.

Hara H, Yokota K, Shimazawa M, Sukamoto T. Hara H, et al. Among authors: shimazawa m. Jpn J Pharmacol. 1993 Apr;61(4):361-5. doi: 10.1254/jjp.61.361. Jpn J Pharmacol. 1993. PMID: 8100595 Free article.

4

Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats.

Shimazawa M, Hara H, Watano T, Sukamoto T. Shimazawa M, et al. Br J Pharmacol. 1995 Aug;115(8):1359-68. doi: 10.1111/j.1476-5381.1995.tb16624.x. Br J Pharmacol. 1995. PMID: 8564192 Free PMC article.

5

An experimental model of migraine with aura: cortical hypoperfusion following spreading depression in the awake and freely moving rat.

Shimazawa M, Hara H. Shimazawa M, et al. Clin Exp Pharmacol Physiol. 1996 Oct-Nov;23(10-11):890-2. doi: 10.1111/j.1440-1681.1996.tb01139.x. Clin Exp Pharmacol Physiol. 1996. PMID: 8911731

6

[Anti-migraine effects of lomerizine].

Hara H, Shimazawa M, Hashimoto M, Sukamoto T. Hara H, et al. Among authors: shimazawa m. Nihon Yakurigaku Zasshi. 1998 Oct;112 Suppl 1:138P-142P. doi: 10.1254/fpj.112.supplement_138. Nihon Yakurigaku Zasshi. 1998. PMID: 10190151 Japanese.

7

Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs.

Hara H, Shimazawa M, Sasaoka M, Yamada C, Iwakura Y, Sakai T, Maeda Y, Yamaguchi T, Sukamoto T, Hashimoto M. Hara H, et al. Among authors: shimazawa m. Clin Exp Pharmacol Physiol. 1999 Nov;26(11):870-6. doi: 10.1046/j.1440-1681.1999.03154.x. Clin Exp Pharmacol Physiol. 1999. PMID: 10561807

8

Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina.

Toriu N, Akaike A, Yasuyoshi H, Zhang S, Kashii S, Honda Y, Shimazawa M, Hara H. Toriu N, et al. Among authors: shimazawa m. Exp Eye Res. 2000 Apr;70(4):475-84. doi: 10.1006/exer.1999.0809. Exp Eye Res. 2000. PMID: 10865996

9

Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits.

Toriu N, Sasaoka M, Shimazawa M, Sugiyama T, Hara H. Toriu N, et al. Among authors: shimazawa m. J Ocul Pharmacol Ther. 2001 Apr;17(2):131-49. doi: 10.1089/10807680151125456. J Ocul Pharmacol Ther. 2001. PMID: 11324981

10

Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models.

Taniguchi T, Shimazawa M, Hara H. Taniguchi T, et al. Among authors: shimazawa m. Brain Res. 2004 Jul 9;1013(2):241-8. doi: 10.1016/j.brainres.2004.04.023. Brain Res. 2004. PMID: 15193534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters